Aqara launches the Thermostat Hub W200, Camera Hub G350, U400 next-gen smart lock, and new spatial sensors at CES 2026 ...

The triple hormone receptor agonist retatrutide reduced body weight and improved pain and physical function in obese/overweight patients with knee osteoarthritis. Topline results were announced from a ...

WASHINGTON — Malfunctioning glucose sensors used by millions of people with diabetes have been tied to more than 700 serious injuries and seven deaths worldwide, according to new information released ...

DJI looks ready to give its tiny handheld camera a meaningful jump in versatility. New leaks hint that the upcoming Osmo Pocket 4 will get a dual-sensor setup, better battery life, and a few design ...

Designed by Nova Radio Labs in the US, the Novaduino Environmental Sensor Kit is an Arduino-programmable air quality and weather monitoring solution built around the company’s own Novaduino Display ...

DARPA's Lift Challenge aims to develop small uncrewed aircraft systems (drones) capable of carrying up to four times their own weight, a substantial leap from the typical 1:1 payload-to-weight ratio.

(RTTNews) - Novo Nordisk (NVO) has released results from its OASIS 4 Phase 3 trial, highlighting the compelling efficacy of oral semaglutide 25 mg as a weight management treatment. The data revealed ...

Please provide your email address to receive an email when new articles are posted on . Adults with overweight or obesity lost significantly more weight at 72 weeks with the oral GLP-1 orforglipron vs ...

Oral semaglutide at a dose of 25 mg may provide an alternative treatment option to injectable semaglutide (2.4 mg) and higher-dose oral semaglutide (50 mg) for persons with overweight or obesity. In a ...

Scientists are racing to improve weight loss treatments beyond drugs like Ozempic and Wegovy, which are effective but plagued by nausea, bone loss, and weight regain. Tufts University chemists have ...